Evidence map›Paper›PMID 42681533›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Large Language Models for Non-Coding RNA Biomarker Discovery in Breast Cancer.

Tamizhini Loganathan

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Tamizhini LoganathanSaveetha Institute of Basic Medical Sciences (SIBMS), Saveetha Institute of Medical and Technical Sciences - SIMATS, SIMATS, Chennai, 602105, Tamil Nadu, India. tamizhiniloga@gmail.com.ORCID http://orcid.org/0000-0002-7736-7885

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) remains a leading cause of cancer-related mortality globally, driven by its molecular heterogeneity and complex tumor biology. Early and accurate detection is critical for improving patient survival and guiding targeted therapies. Noncoding RNAs (ncRNAs), particularly circular RNAs (circRNAs), small nucleolar RNAs (snoRNAs), and PIWI-interacting RNAs (piRNAs), have emerged as key regulators in cancer progression and as potential biomarkers. However, the sheer volume of omics data and literature poses challenges in extracting actionable insights. Recent advances in large language models (LLMs) offer new opportunities to accelerate biomarker discovery through semantic reasoning, knowledge integration, and pattern recognition. This chapter explores the integration of LLMs with ncRNA biology, focusing on circRNAs, snoRNAs, and piRNAs in BC, and proposes a computational framework for biomarker identification.

Indexed as

Biomarkers, TumorBreast NeoplasmsComputational BiologyRNA, UntranslatedFemaleHumansLarge Language ModelsPiwi-Interacting RNARNA, CircularBiomarkers, TumorPiwi-Interacting RNARNA, CircularRNA, UntranslatedBCBiomarkerLLMncRNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.